スペインの家族における血液静止現象の遺伝的決定因子
J C Souto1, L Almasy, M Borrell
1Unit of Thrombosis and Hemostasis, Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Circulation
|April 4, 2000
まとめ
遺伝的要因は,血静に関連した特徴に大きく影響し,血栓形成のリスクに影響を与えます. この研究では,これらの凝固および線維分解の現象型に対する遺伝的貢献を定量化しています.
科学分野:
- 遺伝学 遺伝学とは
- 血液学 ヘマトロジ
- トロンボシス研究研究
背景:
- 血静性パラメータ (タンパク質C,タンパク質S,活性化タンパク質C抵抗比率) を通して,血栓形成リスクに関連した遺伝子変異.
- 以前の研究では,血静性に対する遺伝的影響が示唆されていたが,相対的な重要性については評価されなかった.
研究 の 目的:
- 血静に関連したフェノタイプに対する遺伝的および環境的要因の相対的な貢献を定量化します.
- さまざまな血液静止測定値の遺伝性と,血栓形成リスクとの関連性を評価する.
主な方法:
- 21の拡張血統の397人の個人に27の血静に関連したフェノタイプを分析しました.
- 共同変数 (性別,年齢,喫煙,ホルモン),遺伝子,共有された環境要因の量化効果.
- 各フェノタイプの遺伝可能性の推定値を計算した.
主要な成果:
- 評価されたすべてのフェノタイプは,有意な遺伝的貢献を示した.
- 相続性の推定値は,共変数修正後に22%から55%であった.
- 活性化タンパク質C抵抗比 (71.3%),活性化部分血栓形成時間 (83.0%),およびXII因子 (67.3%) が最も高い遺伝性を示した.
結論:
- 遺伝的要因は,凝固と線維解離経路内の血静相フェノタイプの変化において重要な役割を果たします.
- これらの発見は,血栓形成リスクに影響を与える新しい遺伝子を特定する可能性を強調しています.
- 強い遺伝的効果は,血栓形成に関連する定量的な血静性特性に影響を及ぼす遺伝子を局所化する道を開く.
関連する概念動画
Genetic Lingo
Overview
Pedigree Analysis
Overview
Background and Environment Affect Phenotype
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...


